<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-KEL23568-6H3-3T-N84"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 S1967 IS: Patients Before Middlemen Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2023-06-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>118th CONGRESS</congress><session>1st Session</session><legis-num>S. 1967</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20230614">June 14, 2023</action-date><action-desc><sponsor name-id="S306">Mr. Menendez</sponsor> (for himself, <cosponsor name-id="S396">Mrs. Blackburn</cosponsor>, <cosponsor name-id="S314">Mr. Tester</cosponsor>, <cosponsor name-id="S411">Mr. Marshall</cosponsor>, <cosponsor name-id="S247">Mr. Wyden</cosponsor>, and <cosponsor name-id="S266">Mr. Crapo</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To amend title XVIII of the Social Security Act to establish requirements relating to the responsibility of pharmacy benefit managers under Medicare part D.</official-title></form><legis-body><section id="S1" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Patients Before Middlemen Act</short-title></quote> or the <quote><short-title>PBM Act</short-title></quote>.</text></section><section id="idd37852d3c35848c681ec9db13acdfed1" section-type="subsequent-section"><enum>2.</enum><header>Responsibility of pharmacy benefit managers under Medicare part D</header><subsection id="id3841ad4dd19b4313b099c812ff137382"><enum>(a)</enum><header>Prescription drug plans</header><text>Section 1860D–12(b) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-112">42 U.S.C. 1395w–112(b)</external-xref>) is amended by adding at the end the following new paragraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="idd0d629377f004c2b99b64f282cd85046"><paragraph id="ida39ba11097524d64b8c373c2a0a75006"><enum>(9)</enum><header>Responsibility of pharmacy benefit managers</header><subparagraph id="id5E224BE97F0C4C788A2B935A54317718"><enum>(A)</enum><header>In general</header><text>Each contract entered into with a PDP sponsor under this part with respect to a prescription drug plan offered by such sponsor shall provide that any pharmacy benefit manager (or affiliate, subsidiary, or agent of a pharmacy benefit manager) acting on behalf of such sponsor—</text><clause id="idcf6729f306d74d33b5ca3ed9117e18de"><enum>(i)</enum><text>derives no income with respect to any services provided in connection with part D utilization from any entity or individual other than bona fide service fees; and</text></clause><clause id="id62273561705048618120b9959a810b4d"><enum>(ii)</enum><text>sets forth in an agreement between the pharmacy benefit manager and the PDP sponsor the amount of any bona fide service fee. The bona fide service fee must be a flat dollar amount, cannot be passed on in whole or in part to another party whether or not the pharmacy benefit manager takes title to the drug, and shall not be directly or indirectly based on, or contingent upon—</text><subclause id="id5a113235ba52470494252d89bc36a7db"><enum>(I)</enum><text>drug price, such as wholesale acquisition cost or drug benchmark price (such as average wholesale price);</text></subclause><subclause id="id40F1B2183718465D9D864B1660A1F05D"><enum>(II)</enum><text>discounts, rebates, fees, or other remuneration with respect to prescription drugs prescribed to enrollees in the plan; or</text></subclause><subclause id="idfdb335d57b6a47aea321ffd7d10f8482"><enum>(III)</enum><text>any other amounts prohibited by the Secretary.</text></subclause></clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id02d3003677c3426d917edd17413f3c4d"><enum>(B)</enum><header>Clarification regarding PDP sponsor acting as PBM</header><text>In the case where a PDP sponsor is acting as a pharmacy benefit manager on behalf of a prescription drug plan offered by the PDP sponsor, the requirements under subparagraph (A) shall not be construed as preventing the PDP sponsor from accepting any rebates, discounts, or price concessions that lower net costs for covered part D drugs.</text></subparagraph><subparagraph id="id205b2e6011284507a45a744d1e4ab1f6"><enum>(C)</enum><header>Certification of compliance</header><text>The PDP sponsor and pharmacy benefit manager shall furnish to the Secretary (in a time and manner specified by the Secretary) an annual certification of compliance with this paragraph, as well as such information as the Secretary determines necessary to carry out this paragraph.</text></subparagraph><subparagraph id="id43eba956d3dc49aa8fc32f544535820f"><enum>(D)</enum><header>Disgorgement of excess amounts received</header><text>A pharmacy benefit manager (or affiliate, subsidiary, or agent of a pharmacy benefit manager) shall disgorge to the Secretary any payment, remuneration, or other amount received in violation of this paragraph or the contract entered into with a PDP sponsor under this part with respect to a prescription drug plan.</text></subparagraph><subparagraph id="id078db694015f4d6f9aec372f35fb2886"><enum>(E)</enum><header>Clarification</header><text>The requirements of this paragraph shall apply regardless of whether the pharmacy benefit manager is a first-tier, downstream, or related entity to the PDP sponsor.</text></subparagraph><subparagraph id="id150bf4ce1da64283b08c17ea57902b70"><enum>(F)</enum><header>Rule of construction</header><text>Nothing in this paragraph shall be construed as prohibiting payments related to reimbursement for ingredient costs to entities that acquire prescription drugs or pharmacy dispensing fees.</text></subparagraph><subparagraph id="id4442e45a2f68434cbb9e8ffc8e07261a"><enum>(G)</enum><header>Definitions</header><text>For purposes of this paragraph:</text><clause id="id4f0512782c054f26a09ca3d999a41954"><enum>(i)</enum><header>Bona fide service fee</header><text>The term <term>bona fide service fee</term> means fair market value for a bona fide, itemized service actually performed on behalf of an entity, that the entity would otherwise perform (or contract for) in the absence of the service arrangement and that are not passed on in whole to a client or customer, whether or not the entity takes title to the drug. </text></clause><clause id="id9fa7b39fe77b471580c97b29f59d3d79"><enum>(ii)</enum><header>Pharmacy benefit manager</header><text>The term <term>pharmacy benefit manager</term> means any person, business, or other entity that, pursuant to an agreement with a PDP sponsor or part D plan either directly or through an intermediary acts as a price negotiator or group purchaser on behalf of such sponsor or plan, or manages the prescription drug benefits provided by such sponsor or plan, including the processing and payment of claims for prescription drugs, the performance of drug utilization review, the processing of drug prior authorization requests, the adjudication of appeals or grievances related to the prescription drug benefit, contracting with network pharmacies, controlling the cost of covered part D drugs, or the provision of services related thereto. Such term includes—</text><subclause id="id560A0AE2B9CF4574B9691BA232E50042"><enum>(I)</enum><text>any person, business, or other entity that carries out one or more of the activities described in the preceding sentence; and</text></subclause><subclause id="id51A3E90BF51B4C21A55F44703CC7C9B5"><enum>(II)</enum><text>any entity that is owned, affiliated, or related under a common ownership structure with such a person, business, or entity (including an entity owned by or affiliated with the PDP sponsor) or that acts as a contractor or agent to such a person, business, or entity,</text></subclause><continuation-text continuation-text-level="clause">irrespective of whether such person, business, or entity calls itself a <term>pharmacy benefit manager</term>.</continuation-text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="id9a762e2dd21c41358289368ebc964f3e"><enum>(b)</enum><header>MA–PD plans</header><text>Section 1857(f)(3) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-27">42 U.S.C. 1395w–27(f)(3)</external-xref>) is amended by adding at the end the following new subparagraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="idf9b468cd201a46c68eed1b9d5c24cc09"><subparagraph id="idf3f92f25c282449ea3aae49f9e9c9ac5"><enum>(E)</enum><header>Responsibility of pharmacy benefit managers</header><text>Section 1860D–12(b)(9).</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section></legis-body></bill> 

